Name: Peking University Hepatology Institute
Basic research, experimental diagnosis and medical care of liver diseases.
Study of epidemiology and factors influencing the progression of HCV infection, optimizing treatment for difficult-to-treat hepatitis C.
Development of therapeutic vaccines against HCV and hepatocellular carcinoma, development novel anti-HBV drugs.
Molecular and immunological mechanisms of HCC pathogenesis, metastasis and recurrence.
Establishment of reference materials of HCV for experimental diagnosis.
Stem cell therapy for liver diseases.
Director: Wei Lai
Contact: Wang Jianghua
Address: Peking University Hepatology Institute, Xizhimen South Street 11th, Xizhimen District, Beijing, 100044, P. R. China